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Abstract
Combined treatment of ischemic stroke with Chi-
nese medicine and exogenous bone marrow mes-
enchymal stem cell (BMSC) transplantation may im-
prove the removal of blood stasis and stimulation
of neogenesis. Chinese medicines that remove
blood stasis not only promote blood circulation
but also calm the endopathic wind, remove heat,
resolve phlegm, remove toxic substances and
strengthen body resistance. The medicinal target-
ing effect of Chinese medicine can promote the
homing of BMSCs, and the synergistic therapeutic
effects of drugs can contribute to BMSC differentia-
tion. As such, exogenous BMSC transplantation has
potential advantages for neogenesis. Chinese medi-
cines and exogenous BMSCs provide complementa-
ry functions for the removal of blood stasis and
stimulation of neogenesis. Therefore, a combina-
tion of Chinese medicine and transplantation of ex-
ogenous BMSCs may be particularly suited to isch-
emic stroke treatment.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
The therapeutic methods for removing blood stasis and
stimulating neogenesis were developed on the basis
that new blood is not generated in the presence of
blood stasis. The stimulation of neogenesis is per-
formed simultaneously with the removal of blood stasis
to cure diseases and restore body energy[1]. Fu
Qing-Zhu, a great authority on gynecology who lived
between the end of the Ming Dynasty and the first
years of the Qing Dynasty, effectively applied this
method, and the Shenghua Decoction he developed
was used as a representative recipe for removing blood
stasis and stimulating neogenesis in later ages. In recent
years, experimental studies on ischemic stroke have
demonstrated that Chinese medicines used for remov-
ing blood stasis and stimulating neogenesis can in-
crease the density of CD31 positive microvessels follow-
ing middle cerebral artery occlusion (MCAO) in rat
brain, and also promote angiogenesis to a certain
degree[2]. However, clinical data indicate that the use of
Chinese medicines alone do not provide satisfactory re-
sults in ischemic stroke treatment.
Since the late 1990s, stem cells have become increasing-
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ly important to medical studies. This is because of their
ability to migrate, proliferate and differentiate follow-
ing transplantation. Human bone marrow-derived mes-
enchymal stem cells (hBMSCs) are suitable for autolo-
gous transplantation in clinical practice because they
are easily obtained from patients and do not induce an
immune reaction[3]. Many studies have demonstrated
that transplantation of BMSCs is able to repair nerve
cells injured by cerebral ischemia and subsequently im-
prove neurological function. Therefore, BMSC trans-
plantation is considered an appropriate new treatment
for ischemic cerebrovascular diseases[4]. In recent years,
Chinese medicine has played an increasingly important
role in treatment involving BMSC transplantation. For
example, the TCM concept of wholism has influenced
the culture, differentiation and migration of stem cells.
The concept of preventing the onset and deterioration
of disease has influenced the migration of BMSCs. The
Chinese medicine characteristics of multi-causes and
steady effects, multi-targets, low toxicity or minimal
side effects, may play an important role in stem cell
transplantation[5]. Therefore, exploring the use of Chi-
nese medicines combined with exogenous BMSC trans-
plantation for the treatment of ischemic cerebrovascu-
lar diseases is of great importance, because the method
for removing blood stasis and stimulating neogenesis is
considered to conform to the TCM theory for the
pathogenesis of ischemic stroke. Ischemic stroke treat-
ment with Chinese medicines combined with exoge-
nous BMSC transplantation may enable improved re-
moval of blood stasis and stimulation of neogenesis.
Potential Advantages of Removing Blood Stasis Follow-
ing Ischemic Stroke by Combined Treatment with Chi-
nese Medicine and Exogenous BMSC Transplantation
According to TCM, the pathogenesis of ischemic
stroke follows a dynamic development course, which
goes through various stages including Zang- and Fu-or-
gan functional abnormalities, Qi, blood and body fluid
disorders, and formation of poisons that affect the
brain and injure collaterals[6]. The pathological prod-
ucts and pathogenic factors of wind, fire, phlegm,
blood stasis and poison, arise one after another and
continually injure the brain collaterals, brain marrow
and mentality to induce confusion and unconscious-
ness. Therefore, the removal of wind, fire, phlegm,
blood stasis and poison following their onset may alle-
viate injury to mental activity and Zang- and Fu-or-
gans. Removal of blood stasis should not be considered
a way of promoting blood circulation only, but also for
calming the endopathic wind, removing heat, resolving
phlegm, removing toxic substances and strengthening
body resistance. For the treatment of ischemic cerebro-
vascular diseases with Chinese medicines combined
with exogenous BMSC transplantation, the selection
of the Chinese medicine should not be limited only to
drugs that remove blood stasis by promoting blood cir-
culation. Various options are discussed below.
Chinese medicines for supplementing or invigorating
Qi and promoting blood circulation
As the active component of classical Buzhong Yiqi De-
coction, hexadecanoic acid may promote the prolifera-
tion and migration of BMSCs[7]. For example, in
MCAO rats treated with Buyang Huanwu Decoction
in combination with BMSC transplantation, the infarc-
tion zone was significantly reduced and neurological
functional recovery was promoted[8].
Chinese medicines for supplementing Qi, promoting
blood circulation and resolving phlegm
Naomai Capsule I is a Chinese medicine compound
that functions to supplement Qi, activate blood circula-
tion and resolve phlegm. In a study on the effects of
Naomai Capsule I combined with BMSC transplanta-
tion on angiogenesis and neurological function in the
rat following cerebral ischemia and reperfusion, it was
found that Naomai Capsule I could significantly in-
crease CD31 expression in the ischemic lesion zone.
These results indicated that this drug could induce and
promote angiogenesis, and improve neurological func-
tion, following BMSC transplantation. Moreover, the
effects became more obvious as the therapeutic time
course increased[9].
Chinese medicines for removing heat and toxic
substances
The effects of rhubarb aglycone, which is obtained by
ethanol extraction of Dahuang (Radix et Rhizoma
Rhei), combined with BMSC transplantation was test-
ed in the rat model of MCAO. This treatment regulat-
ed the matrix metalloproteinase-9 (MMP-9) imbalance
by increasing the expression of tissue inhibitor of metal-
loproteinase -1 (TIMP-1), which reduced the degrada-
tion of collagen IV (Col IV) in microvascular basement
membrane at different stages following BMSC trans-
plantation. Subsequently, permeabilization of the blood
–brain barrier (BBB) was alleviated, enabling it to per-
form its protective function[10].
Chinese medicines for supplementing Qi, promoting
blood circulation and removing toxic substances
Naomai Tong functions to supplement Qi, promote
blood circulation and remove toxic substances. LI Ji-
an-sheng, et al.[11] reported that Naomai Tong com-
bined with BMSC transplantation could improve cere-
bral circulation in rat brain and protect tissue from in-
jury. These effects possibly involved the down-regula-
tion of Fas and FasL expression during the early stages
of cerebral ischemia, followed by inhibition of cas-
pase-3-induced apoptosis of nerve cells.
Chinese medicines for tonifying the kidney
Administration of BMSCs incubated with Dihuang
Yinzi promoted HSP70 and vascular endothelial
growth factor (VEGF) expression in the rat following
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cerebral infarction[12]. It was also found that Yougui
Pill, Zuogui Pill, Dihuang Yinzi, retinoic acid (RA)
and recipes for tonifying the kidney combined with
RA could promote the secretion of nerve growth fac-
tor-beta (NGF-β), brain-derived neurotrophic factor
(BDNF) and VEGF by BMSCs. The classical prescrip-
tions for tonifying the kidney-yin and both the kid-
ney-yin and yang were superior to the classical prescrip-
tion for tonifying kidney-yang in promoting BDNF or
VEGF secretion by BMSCs[13].
Potential advantages of exogenous BMSC
transplantation for neogenesis
Studies have shown that following cerebral infarction
in rats, some Chinese medicines such as Zhutan Ton-
gluo Prescription promote the proliferation of endoge-
nous stem cells, which then differentiate into neurons
that promote neurological function recovery[14]. Howev-
er, the biological activities of endogenous neural stem
cells are influenced by ischemic injury, and the repair
of nervous injury and improvement of neurological
function are therefore limited. The traditional method
for removing blood stasis and stimulating neogenesis
does not achieve satisfactory results in the repair of
nerve injury induced by local cerebral ischemia, and so
exogenous BMSC transplantation is potentially advan-
tageous. In addition to removing blood stasis, Chinese
medicine has a medicinal targeting effect that can pro-
mote the successful migration and differentiation of ex-
ogenous BMSCs to further stimulate neogenesis.
The Medicinal targeting effect of Chinese medicine
can promote the homing of BMSCs
Many studies have shown that BMSCs are able to mi-
grate into ischemic tissue. Following local cerebral isch-
emia, destruction of the BBB may possibly contribute
to the selective migration of BMSCs into the ischemic
zone[15]. In addition, inflammatory injury of ischemic
brain tissue and the expression of many chemotactic cy-
tokines, particularly stromal cell-derived factor-1
(SDF-1) and its specific receptor, chemokine (CXC
motif ) receptor-4 (CXCR4), play an important role
during the interaction of the migrating BMSCs with
the injured tissue[16]. Therefore, the number of homed
stem cells very possibly determines the degree to which
the ischemic tissue is repaired. Traditional Chinese
medicines have a selective medicinal targeting effect,
which can be applied to promote the homing of BM-
SCs. For example, Chinese medicines such as Bing Pi-
an (Borneolum), She Xiang (Moschus), Shi Chang Pu
(Rhizome Acori Graminei) etc., which restore con-
sciousness and induce resuscitation, are highly fat-solu-
ble and are of very low molecular weight. Such com-
pounds can easily permeate the BBB to rapidly enter
the brain, and have double-directional permeability
across the BBB. They can also improve the function of
the BBB and protect brain tissues by guiding other
medical compositions to the target point. In addition
to permeating the BBB themselves, they can also pro-
mote permeation of the BBB by other drugs to in-
crease the therapeutic effect[17]. Therefore, transplanta-
tion of BMSCs combined with Chinese medicines that
restore consciousness and induce resuscitation may
help BMSCs permeate the BBB. Another advantage of
this medicinal targeting effect is the guidance of the
BMSCs towards the injured ischemic brain tissue.
Synergistic therapeutic effects of drugs and BMSC
differentiation
BMSCs are multipotent and can differentiate into os-
teoblasts, chondroblasts, muscle tendon, adipose cells,
neurons and astrocytes etc., under appropriate condi-
tions. This characteristic of BMSCs correlates highly
with the TCM theory of the essence of life. Through
tissue engineering studies using stem cells, researchers
are studying the formation and regeneration of tissues
and organs. This indicates that stem cells are the es-
sence of human life because they can regenerate various
human tissues and they conform to the basic property
of maintaining living organs[18]. Therefore, transplanta-
tion of exogenous BMSCs reflects the TCM method of
replenishing essence in ischemic stroke treatment, and
Chinese medicine provides a synergistic therapeutic ef-
fect that can promote essence by differentiating and re-
pairing the injured brain marrow. It has been reported
that Chinese medicines, including Danshen Injection,
polypeptide of musk, total saponin of notoginseng,
cryptotanshinone, Shenghuang Liquid, Astragalus
Root, tortoise plastron liquid, Huangqi Injection, Ren-
shen Injection, Danggui Injection, Naoxinshu Oral
Liquid and Renshen Wang Jiang Oral Liquid, etc., can
induce BMSCs to differentiate into neuron-like cells in
vitro[19]. Chinese medicines may therefore contribute to
neogenesis by stimulating the differentiation and repair
of injured nervous tissue. However, neogenesis not on-
ly promotes nervous tissue repair but also angiogenesis
to provide a rich blood supply to the nervous tissue fol-
lowing ischemic stroke. Over-expression of SDF-1 in
the local ischemic tissue was shown to increase the mi-
gration of BMSCs from peripheral blood and mediate
the homing of endothelial progenitor cells to the isch-
emic tissue, where they induced angiogenesis and fur-
ther tissue repair[16]. Thus, the synergistic therapeutic ef-
fect of Chinese medicines for promoting angiogenesis
in the ischemic zone may further improve neogenesis.
It can be seen from the above discussion that the com-
bination of Chinese medicine with transplantation of
exogenous BMSCs may be potentially advantageous
for removing blood stasis and stimulating neogenesis
during treatment of ischemic stroke. Chinese medi-
cines and exogenous BMSCs provide complementary
functions for the removal of blood stasis and stimula-
tion of neogenesis. Therefore, a combination of Chi-
nese medicine and transplantation of exogenous BM-
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SCs may be particularly suited to ischemic stroke treat-
ment.
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